BREAKING: Futures Fall After Growth-Led Market Sell-Off Cidara Therapeutics (CDTX) shares doubled, and then some, on Friday after Merck (MRK) agreed to buy the biotech company for $9.2 billion. YOU MAY ALSO LIKE: Bristol Myers Slumps After Its Heart Condition Study Gets The Boot Avadel Surges 20% On Lundbeck's Surprise Alkermes-Topping Bid Looking For The Next Big Stock Market Winners? Start With These 3 Steps Want More IBD Insights? Subscribe To Our Investing Podcast! The deal is "nothing to sneeze at," RB ...